Streetbeat News

Regulatory

QURE

uniQure has dosed the first patient in its Phase I/IIa clinical trial of AMT-191, a gene therapy for Fabry disease. This marks a significant milestone in the development of treatments for this rare genetic disorder.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:09 am

BNBUSD

USTUSD

Changpeng Zhao (CZ), the former CEO of Binance, was sentenced to four months in prison for failing to establish an effective anti-money laundering program. His net worth has dropped from $40 billion to $28.2 billion. Binance agreed to pay $4.3 billion in fines, and Richard Teng is now the CEO. The native token BNB is down 1.34% in the last 24 hours but has grown 65% YTD.

Portfolio Pulse from Aniket Verma

August 15, 2024 | 11:00 am

KALV

The European Medicines Agency has validated KalVista Pharmaceuticals' marketing application for Sebetralstat, a treatment for hereditary angioedema.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:35 am

ALK

HA

Alaska Air and Hawaiian Airlines have agreed with the Department of Justice to extend the review period of their proposed merger until August 20, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:29 am

FXI

China's Central Bank Governor stated that the overall Chinese financial system is relatively stable, with a decline in the number of local government financing platforms and the size of debt.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 10:27 am

BP

EIPX

HJEN

SHEL

BP p.l.c. (NYSE:BP) informed federal regulators that Venture Global LNG does not need additional time to start commercial production at its Calcasieu Pass plant. This plant has been central to a dispute involving BP and Shell plc (NYSE:SHEL) over LNG access. The plant is expected to bolster the U.S.'s position as a leading LNG exporter. BP shares are up 0.77% premarket.

Portfolio Pulse from Lekha Gupta

August 15, 2024 | 10:24 am

WENA

ANEW Medical, Inc. (NASDAQ:WENA) has secured a U.S. patent for its Klotho gene therapy targeting neurodegenerative diseases. This patent strengthens ANEW's IP portfolio, which includes exclusive worldwide rights to develop and commercialize treatments for conditions like Alzheimer's, ALS, and Parkinson's disease.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 9:03 am

AZN

The FDA has accepted AstraZeneca's supplemental biologics license application for Imfinzi (Durvalumab) under priority review for limited-stage small cell lung cancer. The Prescription Drug User Fee Act date is anticipated during the fourth quarter of 2024.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 8:55 am

ALVO

The European Medicines Agency (EMA) has accepted Alvotech and Advanz Pharma's Marketing Authorization Application for AVT06, a biosimilar to Eylea. The authorization process could be completed by Q3 2025.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 8:32 am

GOOG

GOOGL

Gene Munster from Deepwater Asset Management discussed the potential breakup of Alphabet Inc. (GOOG, GOOGL) on CNBC's 'Fast Money,' suggesting it could unlock 20% value. However, he believes the probability of a voluntary breakup is exceptionally low. The discussion comes amid ongoing DOJ investigations into Google's market dominance.

Portfolio Pulse from Ananya Gairola

August 15, 2024 | 8:23 am